NewsRoom Articles - Page 105 of 112

ThursdayFeb 01, 2018 3:58 pm

Pivot Pharmaceuticals Inc. (PVOTF) is “One to Watch”

Transdermal cannabis-based therapy promises greater absorption, less side effects Global medical marijuana market projected to reach $55.8 billion U.S. by 2025 Novel CBD delivery method targets array of unmet healthcare needs Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), based in Vancouver, Canada, is an emerging biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals that provide novel treatments for unmet healthcare needs. Pivot’s recent acquisition of BiPhasix ™ Transdermal Drug Delivery technology for the delivery of cannabinoids (CBD) to patients provides the answer for an age-old problem associated with cannabinoid-based therapies: the lack of a robust smoke-less delivery mechanism.…

ThursdayFeb 01, 2018 3:29 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Teams with UniQuest to Develop Novel Cannabinoid Delivery System

Global nasal drug delivery technology market expected to reach $64 billion by 2021 Development of CBD-infused soluble gel for nasal delivery targets range of diseases Clinical benefits of Sol-gel delivery method include a safer, more reliable delivery platform with higher efficacy Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) and UniQuest Pty Limited, the main commercialization company of the University of Queensland (UQ), Australia, are expecting 2018 to be an exciting, productive year for joint medical research projects. PreveCeutical Medical, headquartered in Vancouver, British Columbia, has entered into a research and option agreement with the University and…

ThursdayFeb 01, 2018 12:04 pm

Golden Leaf Holdings, Ltd. (OTCQB: GLDFF) (CSE: GLH) Subsidiary Receives First Genetics at Ontario Plant-Growing Facility

Company plans mid-2018 commencement of adult-use market sales in Canada as it addresses medical segment opportunity The firm received its cultivation license during the fourth quarter of 2017, anticipates receiving its sales license by May Phillip Millar, MMG president, said company’s portfolio includes genetic strain that holds the highest level of CBD in Canada, sees potential in medical segment and for European export Golden Leaf Holdings, Ltd. (OTCQB: GLDFF) (CSE: GLH) recently announced that its subsidiary, Medical Marijuana Group ("MMG"), has received its first order of genetics at its St. Thomas, Ontario facility as it transitions from a production location…

MondayJan 29, 2018 1:55 pm

The Green Organic Dutchman Boosts Financing to $160 Million with Strategic Investment by Aurora Cannabis

The Green Organic Dutchman Holdings Ltd., also known as TGOD, recently announced the closing of $112 million in private placement financing, including a strategic investment by marijuana industry powerhouse Aurora Cannabis Inc. (OTCQX: ACBFF) (TSX: ACB) of $55 million. TGOD issued 67,878,788 units at a price of $1.65 per unit. Each unit included one common share of the company and a half common share purchase warrant that can be converted to a full share at the exercise price of $3 each during the next three years. The investment fully funds the expansion of TGOD’s combined 970,000 square-foot ultra-high technology greenhouse…

FridayJan 26, 2018 1:11 pm

NeutriSci International Inc. (TSX.V: NU) (OTCQB: NRXCF) (FRA: 1N9) – From Nutraceuticals to Cannabinoid Pharmaceuticals

Patented nutraceuticals with retail distribution and consumer branding expertise MOU with cannabinoid pharma for research on NeutriSci products for new therapeutics Targeting forefront of new and innovative cannabinoid-based medical products in Canada In business for nearly a decade, NeutriSci International Inc. (TSX.V: NU) (OTCQB: NRXCF) (FRA: 1N9) has become an established leader in the Canadian nutraceutical markets and continues to develop new sales channels throughout the U.S., Europe and Asia. The company is not only expanding its existing national retail footprint in Canada; it just entered into a major R&D Memorandum of Understanding with Scientus Pharma Inc. to develop, produce…

FridayJan 26, 2018 9:40 am

Choom™ (CSE: CHOO) (OTCQB: CHOOF) Cultivating an Exceptional Consumer Experience

Branding and retail focused to capture large share of $8.7 billion Canadian recreational cannabis market Developing chain of branded retail cannabis dispensaries – just announced new retail store concept Intends to establish a significant retail footprint in the Canadian recreational cannabis markets The laid back Hawaiian lifestyle is the envy of the world. Surfers and sun worshipers enjoy life and, for decades, have relaxed with ‘choom’, the local name for marijuana. Now a company, Choom™ (CSE: CHOO) (OTCQB: CHOOF) is bringing the spirit and lifestyle of Hawaii to Canada. Choom™ is a high-quality hand-crafted cannabis brand created exclusively for the…

ThursdayJan 25, 2018 3:53 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Technology Offers Potentially Safer Method of Delivering Drug Therapies

Only company in the world with patent for the oral or ingestible delivery of all non-psychoactive cannabinoids Uplisted to OTCQX® Best Market Licensing model generates profit margins in excess of 90 percent A new report by the National Academies of Sciences, Engineering and Medicine is the most comprehensive analysis of existing research on e-cigarettes, according to the New York Times (http://cnw.fm/Eay21). While warning against the risk of nicotine addiction posed by vaping, the report claimed “that the devices are safer than traditional smoking products and may help smokers quit, citing conclusive proof that switching can reduce smokers’ exposure to deadly…

ThursdayJan 25, 2018 12:35 pm

Liberty Leaf Holdings Ltd. (OTCQB: LIBFF) (CSE: LIB) (FSE: HN3P) Closes $2 Million in Private Placement Financing

Company’s subsidiaries set sights on recreational use licensing, expansion Total marijuana market in Canada forecast to hit $2.8 billion by 2020 Pet cannabis products for pain expected to form large market opportunity Liberty Leaf Holdings Ltd. (OTCQB: LIBFF) (CSE: LIB) (FSE: HN3P) announced on January 22 that it had closed a private placement financing effort with $2 million in gross proceeds that will be used to speed completion of facility construction projects for its subsidiaries, North Road Ventures in the greater Vancouver area of Canada’s British Columbia and Just Kush Enterprises, located some 250 miles to the east. Just Kush…

TuesdayJan 23, 2018 1:07 pm

Disrupting Drug Delivery Platform Keeps Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) Portfolio Growing

Patented technology promotes healthier administration of active pharmaceutical ingredients, including cannabidiol (CBD), psychoactive cannabinoids (THC), nicotine, fat soluble vitamins and nonsteroidal anti-inflammatory drugs Active pharmaceutical ingredient market expected to exceed $239 billion by 2025 19 patent applications filed in U.S. and internationally encompassing 44 countries Lab tests in 2018 include topical CBD skin cream, nicotine in edible formats Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a research-driven company that has developed and out-licenses a patented drug delivery platform called DehydraTECH™ that changes the way active pharmaceutical ingredients (“APIs”) enter the body orally. According to a new report by Million…

FridayJan 19, 2018 12:27 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Combining Nature and Science to Make Life Better

Company utilizing novel Caribbean blue scorpion venom therapy for immune system boost PreveCeutical seeks new ways to treat cancers, metabolic disorders, pain, infectious diseases and cardiovascular disease Partnership with University of Queensland researchers advances scientific scope of projects In the modern health care industry, disease prevention has taken a commanding role as screenings and regularly scheduled physician visits aim to minimize costs that could otherwise spiral out of control once a chronic condition is established. However, the Centers for Disease Control and Prevention report an ongoing concern that Americans are using preventive services at about half the recommended rate (http://cnw.fm/OIa4V).…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 905.674.5977